RWPC Logo

Members

Consortium members and collaborators

Alexandre Lehmann

πŸ“ Canada

McGill University, Canada

Research Interests

Real-world data, practice-based research network, informing policy, music and plasticity

Contact

Alexis Arragon

πŸ“ France

French Psychedelic Society/ PsychedeliCare

Research Interests

Advocacy for psychedelic therapies, policy work in Europe, general public destigmatization and education

Contact

Amandine Luquiens

πŸ“ France

Professor at UniversitΓ© de Montpellier

Contact

Brock Pluimer

πŸ“ USA

University of California, Irvine

Research Interests

ibogaine, opioid use disorder

Contact

Daniel J. Kruger

πŸ“ USA

University at Buffalo; University of Michigan

Research Interests

Survey research, many topics

Contact

Diego Pinzon Rubiano

Contact

Eduardo Schenberg

πŸ“ Portugal

Faculty of Medicine, University of Lisbon, Portugal

Research Interests

epistemology, evidence assessments, trial designs, social justice, ethics, indigenous rights, history, mechanisms and more

Contact

Farnaz Younessi Sisi

πŸ“ Iran

Yaadmaan Institute for Brain, Cognition and Memory Studies, Tehran, Iran; Cognitive Neurology and Neuropsychiatry Research Center, Tehran University of Medical Sciences (TUMS), Tehran, Iran

Research Interests

Mechanisms of therapeutic action; Domain-based, neuroscience-informed investigation of psychedelics in neurological conditions

Contact

Futaba Ummeura

πŸ“ Japan

Niigata University Graduate School, Tokyo Metropolitan institute of Medicine Science (TMiMS), National Center of Neurology and Psychiatry (NCNP), Japan

Research Interests

Real World Psychedelic Use, Harm Reduction, Online Survey, PAT

Contact

Galia J Benitez

πŸ“ USA

Michigan State University

Research Interests

Psychedelics, ritual uses, other uses, indigenous uses, sources, government policies or regulations

Contact

Jamarie Geller

πŸ“ USA

Michigan Medicine

Research Interests

MDMA, ketamine, adolescent tx

Contact

Juliet Meccia

Porta Sophia

Research Interests

Patents, policy, Indigenous rights protection

Contact

Julio Cesar Camargo Silva

πŸ“ Canada

University of British Columbia (UBC) - alumnus

Research Interests

Psychedelic Assisted Therapy (PAT); mental health; psychiatry; treatment methodology; cultural aspects of substance use; community-based research; indigenous rights

Contact

Kari Rockhill

πŸ“ USA

Rocky Mountain Poison & Drug Safety

Research Interests

real-world psychedelic use, epidemiological surveillance, safety monitoring

Contact

Kate Reynolds

πŸ“ USA

Director of Research at Rocky Mountain Poison & Drug Safety

Contact

Katie Pickard

Unlimited Sciences

Research Interests

Real world psychedelic use, evidence-based education, harm reduction, policy change

Contact

Kristel Carrington

Doctors for Drug Policy Reform

Research Interests

Evidence-based drug policy reform, education, access to psychedelics, decriminalization

Contact

Kyle Greenway

πŸ“ Canada

McGill University

Research Interests

Therapeutic applications, music, phenomenology

Contact

Lani Roy

πŸ“ Australia

Chair, Australian Multidisciplinary Association Psychedelic Practitioners

Research Interests

harm reduction, preparation, integration, PTSD/sexual abuse - all areas

Contact

LucΓ­a Levenberg

πŸ“ Argentina

Independent

Research Interests

Real world bond with entheogens and psychedelics data, neuroaffirmative and gender affirmative practices in psychedelics, policy change for safe access, ethics, professionals continue education, chronic illness

Contact

Mahmoud Elmidany

πŸ“ UK

cambridge university hospitals

Research Interests

Qualitative experiences of real world use of psychedelics

Contact

Matthew Hicks

πŸ“ USA

National University of Natural Medicine; Synaptic Institute

Research Interests

Ketamine, Psilocybin, 5-MeO-DMT research focused on depression, PTSD and accessibility

Contact

Michel Dorval

πŸ“ Canada

UniversitΓ© Laval, QuΓ©bec, Canada

Research Interests

Palliative care; psilocybin-assisted therapy; epidemiology

Contact

Michelle St. Pierre

πŸ“ Canada

UBC; BC Centre on Substance Use (BCCSU)

Research Interests

Psychedelics (incl. microdosing, ketamine), cannabis, mental health

Contact

Niloufar Pouyan

πŸ“ USA

University of Michigan

Research Interests

Mechanisms of therapeutic action; Domain-based, neuroscience-informed investigation of psychedelics in psychiatric conditions and chronic pain

Contact

Omer Syed

πŸ“ Canada

University of Toronto

Research Interests

Real world psychedelic use, microdosing, ketamine

Contact

Pamela Kryskow

πŸ“ Canada

UBC/VIU/Roots To Thrive

Research Interests

Real patients, real therapy, real outcomes

Contact

Paul Liknaitzky

πŸ“ Australia

Monash University, Australia

Research Interests

Clinical trials, psychedelic psychotherapies, psychedelic-catalysed insight, therapist training, psychedelic-assisted training, extended uses of PAT

Contact

Pedram Dara

Psychedelic Lived Experiences

Research Interests

Lived experience expertise (clinical trial participants and patients)

Contact

Pedro Teixeira

πŸ“ Portugal

University of Lisbon - Faculty of Human Kinetics

Research Interests

Psychedelics, health behaviors, prevention, public health

Contact

Philippe Lucas

πŸ“ USA

MAPS/Michigan Psychedelic Center

Research Interests

Real World psychedelic use

Contact

Pinni (Pinchas) Baumol

πŸ“ Israel

Tel-aviv University, Shaare Nefesh resilience center, ACPT

Research Interests

PAT for PTSD/Harm reduction/Policy change social work

Contact

Rick Harris

πŸ“ USA

University of California, Irvine

Research Interests

Psychedelics for chronic pain and opioid addiction

Contact

Roman Palitsky

πŸ“ USA

Emory University

Research Interests

Safety, Spirituality, Therapeutics

Contact

Rotem Petranker

πŸ“ Canada

Canadian Centre for Psychedelic Science AND ALSO McMaster University

Research Interests

Psychedelics; microdosing; open science; methodology; clinical trial design

Contact

Sam Lasham

πŸ“ New Zealand

University of Auckland, New Zealand, Students for Sensible Drug Policy Aotearoa New Zealand

Research Interests

Real world use of psychedelics, harm reduction, drug checking, and beneficial illicit drug use

Contact

Sara de la Salle

πŸ“ Canada

McGill University

Research Interests

Psychedelics and music, mindfulness, absorption, imprinting (visual hallucinations)

Contact

Sara Gloeckler

πŸ“ Canada

McGill University

Research Interests

Psychedelics and music, social determinants of health

Contact

Sue-Ling Chang

πŸ“ Canada

Centre de recherche du CHU de QuΓ©bec-UniversitΓ© Laval, QuΓ©bec, Canada

Research Interests

Palliative care, psilocybin-assisted therapy, epidemiology

Contact

Toshihiko Matsumoto

πŸ“ Japan

Department of Drug Dependence Research at the National Center of Neurology and Psychiatry (NCNP), Japan

Research Interests

Substance Use Disorder treatment, Harm Reduction, Policy, Psychedelic use in Japan

Contact

TΓΊlio Pereira Alvarenga e Castro

πŸ“ Brazil

Universidade Federal dos Vales do Jequitinhonha e Mucuri

Research Interests

DMT; Psilocybin; psychiatry; addiction medicine; medical anthropology; community; traditional healing; nature relatedness

Contact

Vincent Joralemon

πŸ“ USA

Director, Berkeley Law Life Sciences Law & Policy Center

Research Interests

FDA Approval, patents, commercialization, decriminalization, policy, federalism

Contact

Zach Walsh

πŸ“ Canada

University of British Columbia

Research Interests

psychedelics and cannabis for problematic substance use; psychedelic access

Contact
Showing 43 consortium members